玉屏风散联合罗红霉素在支气管扩张稳定期患者中的应用价值

Application Value of Yupingfeng Powder Combined with Roxithromycin in Patients in Stable Bronchiectasis

目的探讨玉屏风散联合罗红霉素在支气管扩张稳定期患者中的应用价值。方法选取2018年2月至2019年9月上栗县中医院收治的支气管扩张稳定期患者60例作为研究对象,随机分为3组,每组20例。A组采用常规治疗,B组在A组基础上采用罗红霉素治疗,C组在B组基础上服用玉屏风散。比较3组病情变化、复发年度住院次数和并发症发生率。结果 C组血常规恢复正常时间、症状消失时间、住院时间均明显短于A、B组,差异有统计学意义(P<0.05);治疗后,3组复发年度住院次数下降,且C组下降幅度大于A、B组,差异有统计学意义(P<0.05);C组并发症发生率明显低于A、B组,差异有统计学意义(P<0.05)。结论玉屏风散联合罗红霉素可有效减少支气管扩张稳定期患者复发年度住院次数,降低并发症发生率,促进患者早日康复。

Objective To explore the application value of Yupingfeng Powder combined with roxithromycin in patients in stable bronchiectasis. Methods From February 2018 to September 2019, 60 patients with stable stage of bronchiectasis admitted to Shangli County Hospital of Traditional Chinese medicine were selected and randomly divided into 3 groups, with 20 in each group. Group A received routine treatment, group B received roxithromycin on the basis of group A, and group C received Yupingfeng Powder on the basis of group B. The changes of disease, the number of hospital stay and the incidence of complications in 3 groups were compared. Results The time to normal blood return, symptom disappearance, and length of hospital stay in group C were significantly shorter than those in groups A and B(P<0.05). After treatment, the number of annual hospitalizations for recurrence in the 3 groups decreased, and group C was greater than those in groups A and B(P<0.05). Conclusion Yupingfeng Powder combined with roxithromycin can effectively reduce the number of annual hospitalizations for patients with stable bronchiectasis during relapse, reduce the incidence of complications, and promote the early recovery of patients.